Earlier reports that show an increase in the protein levels of BDNF in the forebrain in APPsw mice [90] and area CA1 in Aβ-treated rats [19], suggest that in early AD, a protective mechanism may be activated to counter the Aβ-induced neurotoxicity. The gene discussed is BDNF; the disease is Alzheimer disease.